Ping Chen

机构：University of Nottingham Ningbo China, Fourth Affiliated Hospital of China Medical University, Shenzhen Institutes of Advanced Technology, China Medical University · ORCID：0000-0001-7815-7532

发表论文 564 篇 · 总被引 11991 次 · h-index 57

代表论文

• Parecoxib sequential with imrecoxib for occurrence and remission of severe acute pancreatitis: a multicentre, double-blind, randomised, placebo-controlled trial (2025 · Gut · 被引 12)
• Lung-targeted delivery of PTEN mRNA combined with anti-PD-1-mediated immunotherapy for In Situ lung cancer treatment (2025 · Acta Biomaterialia · 被引 10)
• Expression of urinary exosomal miR-136-5p in diabetic kidney disease and evaluation of its clinical diagnostic value (2025 · Scientific Reports · 被引 9)
• The Radiosensitizing Effect of Tumor-Derived Microparticles Co-Loaded with Sorafenib and Gold Nanoparticles on Hepatocellular Carcinoma (2025 · International Journal of Nanomedicine · 被引 4)
• RAD51B-EZH2 axis as a potential therapeutic target for TNBC through cell fate conversion (2025 · Cell Death and Disease · 被引 2)
• Bacterial outer membrane vesicles encapsulated cationic polymer with STING agonist as nanovaccines for enhanced immunotherapy (2025 · Chemical Engineering Journal · 被引 2)